342 related articles for article (PubMed ID: 11312437)
1. Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
O'branski EE; Ware RE; Prose NS; Kinney TR
J Am Acad Dermatol; 2001 May; 44(5):859-61. PubMed ID: 11312437
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.
Altura RA; Wang WC; Wynn L; Altura BM; Altura BT
J Pediatr; 2002 May; 140(5):565-9. PubMed ID: 12032523
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyurea in very young children with sickle cell anemia is not a cure-all.
Powars DR
J Pediatr; 2001 Dec; 139(6):763-4. PubMed ID: 11743496
[No Abstract] [Full Text] [Related]
4. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
Chaine B; Neonato MG; Girot R; Aractingi S
Arch Dermatol; 2001 Apr; 137(4):467-70. PubMed ID: 11295927
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea for sickle cell anemia.
Bachmeyer C; Aractingi S; Lionnet F
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18609755
[No Abstract] [Full Text] [Related]
6. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
Zargari O; Kimyai-Asadi A; Jafroodi M
Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
8. Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease.
Huang Y; Ananthakrishnan T; Eid JE
Am J Hematol; 2003 Oct; 74(2):125-6. PubMed ID: 14508799
[TBL] [Abstract][Full Text] [Related]
9. Are we underestimating the leukemogenic risk of hydroxyurea.
Al-Jam'a AH; Al-Dabbous IA; Al-Khatti AA; Esan FG
Saudi Med J; 2002 Nov; 23(11):1411-3. PubMed ID: 12506308
[TBL] [Abstract][Full Text] [Related]
10. When should hydroxyurea be used for children with sickle cell disease?
Mueller BU
Pediatrics; 2008 Dec; 122(6):1365-6. PubMed ID: 19047256
[No Abstract] [Full Text] [Related]
11. Hydroxurea and sickle cell disease: Its been a long, long time coming.
Scott JP
Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
[No Abstract] [Full Text] [Related]
12. Clinical complications in severe pediatric sickle cell disease and the impact of hydroxyurea.
Tripathi A; Jerrell JM; Stallworth JR
Pediatr Blood Cancer; 2011 Jan; 56(1):90-4. PubMed ID: 20922765
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea in sickle cell disease.
Adams-Graves P; Heltsley C; Deitcher S
N Engl J Med; 1996 Feb; 334(5):333-4. PubMed ID: 8532043
[No Abstract] [Full Text] [Related]
14. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
[TBL] [Abstract][Full Text] [Related]
15. Enalapril and hydroxyurea therapy for children with sickle nephropathy.
Fitzhugh CD; Wigfall DR; Ware RE
Pediatr Blood Cancer; 2005 Dec; 45(7):982-5. PubMed ID: 15704213
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyurea for children with sickle cell disease.
Heeney MM; Ware RE
Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of hydroxyurea for sickle cell anemia.
Spell DW
JAMA; 2003 Aug; 290(6):752; author reply 754. PubMed ID: 12915422
[No Abstract] [Full Text] [Related]
18. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease.
de Montalembert M; Belloy M; Bernaudin F; Gouraud F; Capdeville R; Mardini R; Philippe N; Jais JP; Bardakdjian J; Ducrocq R; Maier-Redelsperger M; Elion J; Labie D; Girot R
J Pediatr Hematol Oncol; 1997; 19(4):313-8. PubMed ID: 9256830
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.
Strouse JJ; Lanzkron S; Beach MC; Haywood C; Park H; Witkop C; Wilson RF; Bass EB; Segal JB
Pediatrics; 2008 Dec; 122(6):1332-42. PubMed ID: 19047254
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease.
Grigg A
Intern Med J; 2007 Mar; 37(3):190-2. PubMed ID: 17316339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
